Skip to main content

Table 3 Serum MDA-LDL levels in patients recruited for this study

From: Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies

 

Immediately after admission

7 d after admission

P

Total (n = 38), U/L

85.4 ± 33.5

82.6 ± 31.5

0.3424

G I (n = 27), U/L

86.8 ± 34.7

86.3 ± 33.1

0.9262

G II (n = 11), U/L

82.1 ± 30.2

73.2 ± 24.6

0.0111

  1. MDA-LDL, malondialdehyde modified-low density lipoprotein.